Anti-VTI1A monoclonal antibody

Pre-made anti-VTI1A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to VTI1A/VTI1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2269-Ab-1/ GM-Tg-hg-IP2269-Ab-2Anti-Human VTI1A monoclonal antibodyHuman
GM-Tg-rg-IP2269-Ab-1/ GM-Tg-rg-IP2269-Ab-2Anti-Rat VTI1A monoclonal antibodyRat
GM-Tg-mg-IP2269-Ab-1/ GM-Tg-mg-IP2269-Ab-2Anti-Mouse VTI1A monoclonal antibodyMouse
GM-Tg-cynog-IP2269-Ab-1/ GM-Tg-cynog-IP2269-Ab-2Anti-Cynomolgus/ Rhesus macaque VTI1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2269-Ab-1/ GM-Tg-felg-IP2269-Ab-2Anti-Feline VTI1A monoclonal antibodyFeline
GM-Tg-cang-IP2269-Ab-1/ GM-Tg-cang-IP2269-Ab-2Anti-Canine VTI1A monoclonal antibodyCanine
GM-Tg-bovg-IP2269-Ab-1/ GM-Tg-bovg-IP2269-Ab-2Anti-Bovine VTI1A monoclonal antibodyBovine
GM-Tg-equg-IP2269-Ab-1/ GM-Tg-equg-IP2269-Ab-2Anti-Equine VTI1A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2269-Ab-1/ GM-Tg-hg-IP2269-Ab-2; GM-Tg-rg-IP2269-Ab-1/ GM-Tg-rg-IP2269-Ab-2;
GM-Tg-mg-IP2269-Ab-1/ GM-Tg-mg-IP2269-Ab-2; GM-Tg-cynog-IP2269-Ab-1/ GM-Tg-cynog-IP2269-Ab-2;
GM-Tg-felg-IP2269-Ab-1/ GM-Tg-felg-IP2269-Ab-2; GM-Tg-cang-IP2269-Ab-1/ GM-Tg-cang-IP2269-Ab-2;
GM-Tg-bovg-IP2269-Ab-1/ GM-Tg-bovg-IP2269-Ab-2; GM-Tg-equg-IP2269-Ab-1/ GM-Tg-equg-IP2269-Ab-2
Products NameAnti-VTI1A monoclonal antibody
Formatmab
Target NameVTI1A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-VTI1A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2269-Ag-1Recombinant multi-species VTI1A/ MMDS3/ MVti1 protein


    Target information

    Target IDGM-IP2269
    Target NameVTI1A
    Gene ID143187,53611,65277,696654,100685447,101095380,780850,100068586
    Gene Symbol and Synonyms1110014F16Rik,1110018K19Rik,4921537J05Rik,DD6A4-2(1),MMDS3,MVti1,MVti1a,Vti1,Vti1-rp2,VTI1A,VTI1RP2
    Uniprot AccessionQ96AJ9,Q9JI51
    Uniprot Entry NameVTI1A_HUMAN,VTI1A_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000151532
    Target ClassificationTumor-associated antigen (TAA)

    The target: VTI1A, gene name: VTI1A, also named as MMDS3, MVti1, VTI1RP2, Vti1-rp2. The protein encoded by this gene is a member of the family of soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptors (SNAREs) that function in intracellular trafficking. This family member is involved in vesicular transport between endosomes and the trans-Golgi network. It is a vesicle-associated SNARE (v-SNARE) that interacts with target membrane SNAREs (t-SNAREs). Polymorphisms in this gene have been associated with binocular function, and also with susceptibility to colorectal and lung cancers. A recurrent rearrangement has been found between this gene and the transcription factor 7-like 2 (TCF7L2) gene in colorectal cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.